KN, B., N, K., Y, L., L, B., IK, D., S, B., & KA, F. (2024). Barriers and facilitators to use of buprenorphine in state-licensed specialty substance use treatment programs: A survey of program leadership. Journal of substance use and addiction treatment, 162, 209351. https://doi.org/10.1016/j.josat.2024.209351
Chicago Style (17th ed.) CitationKN, Burke, Krawczyk N, Li Y, Byrne L, Desai IK, Bandara S, and Feder KA. "Barriers and Facilitators to Use of Buprenorphine in State-licensed Specialty Substance Use Treatment Programs: A Survey of Program Leadership." Journal of Substance Use and Addiction Treatment 162 (2024): 209351. https://doi.org/10.1016/j.josat.2024.209351.
MLA (9th ed.) CitationKN, Burke, et al. "Barriers and Facilitators to Use of Buprenorphine in State-licensed Specialty Substance Use Treatment Programs: A Survey of Program Leadership." Journal of Substance Use and Addiction Treatment, vol. 162, 2024, p. 209351, https://doi.org/10.1016/j.josat.2024.209351.